Sigma lifts guidance after RAT buying surge

But its bottom line is tipped to be in the red due to costs associated with its new technology system and sales disruptions.  

Related Keywords

Australia ,South Africa ,Rowville ,Victoria ,South African ,Australian ,Mark Hooper ,Phil Pepe ,Vikesh Ramsunder ,Australian Pharmaceutical Industries ,Discount Drug Stores ,South African Vikesh Ramsunder ,Chemist King ,